In human genome, generation of a nuclear export signal through duplication appears unique to nucleophosmin (NPM1) mutations and is restricted to AML

被引：0
|
作者：
A Liso
A Bogliolo
V Freschi
M P Martelli
S A Pileri
M Santodirocco
N Bolli
M F Martelli
B Falini
机构：
[1] Institute of Haematology,Department of Medical and Occupational Sciences
[2] University of Foggia,undefined
[3] Foggia,undefined
[4] Italy,undefined
[5] Information Science and Technology Institute (ISTI),undefined
[6] University of Urbino,undefined
[7] Institute of Haematology,undefined
[8] University of Bari,undefined
[9] Institute of Haematology,undefined
[10] Haematopathology Unit,undefined
[11] University of Bologna,undefined
[12] Policlinico S. Orsola,undefined
[13] Institute of Haematology,undefined
[14] University of Perugia,undefined
来源：
Leukemia | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1285 / 1289
页数：4
相关论文
共 26 条
  • [21] Fms Like Tyrosine Kinase (FLT3) and Nucleophosmin 1 (NPM1) Mutations in De Novo Normal Karyotype Acute Myeloid Leukemia (AML)
    Dunna, Nageswara Rao
    Rajappa, Senthil
    Digumarti, Raghunadharao
    Vure, Sugunakar
    Kagita, Sailaja
    Damineni, Surekha
    Rao, V. R.
    Yadav, Satish Kumar
    Ravuri, Rajasekhara Reddy
    Satti, Vishnupriya
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2010, 11 (06) : 1811 - 1816
  • [22] Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML):: association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance
    Verhaak, RGW
    Goudswaard, CS
    van Putten, W
    Bijl, MA
    Sanders, MA
    Hugens, W
    Uitterlinden, AG
    Erpelinck, CAJ
    Delwel, R
    Löwenberg, B
    Valk, PJM
    BLOOD, 2005, 106 (12) : 3747 - 3754
  • [23] Myelodysplastic Syndromes with NPM1 Mutations May Constitute a Unique Entity Associated with Improved Outcomes When Treated with AML-like Chemotherapy
    Montalban-Bravo, Guillermo
    Pierola, Ana Alfonso
    Takahashi, Koichi
    Jabbour, Elias J.
    Kadia, Tapan M.
    Ravandi, Farhad
    Cortes, Jorge E.
    DiNardo, Courtney D.
    Daver, Naval G.
    Borthakur, Gautam
    Pemmaraju, Naveen
    Konopleva, Marina
    Pierce, Sherry
    Bueso-Ramos, Carlos E.
    Patel, Keyur
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    BLOOD, 2016, 128 (22)
  • [24] In AML with normal karyotype lacking mutations in NPM1, CEBPA, RUNX1 and MLL partial tandem duplication array CGH and fluorescence in situ hybridization can add prognostic information
    Haferlach, C.
    Kern, W.
    Zieschang, K.
    Zenger, M.
    Perglerova, K.
    Haferlach, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 48 - 49
  • [25] Prognostic Impact of Mutations in the Nucleophosmin (NPM1) and of the FMS-Related Tyrosine Kinase 3 (FLT3) Genes in Elderly Patients with Acute Myeloid Leukemia (AML) Treated with Intensive Chemotherapy.
    Etienne, Anne
    Borel, Cecile
    Reutenauer, Sarah
    Olschwang, Sylviane
    Mozziconacci, Marie-Joelle
    Delabesse, Eric
    Demur, Cecile
    Prebet, Thomas
    Huguet, Francoise
    Charbonnier, Aude
    Recher, Christian
    Vey, Norbert
    BLOOD, 2008, 112 (11) : 883 - 883
  • [26] Mutations in the nuclear export signal of human Ran-binding protein RanBP1 block the Rev-mediated posttranscriptional regulation of human immunodeficiency virus type 1
    Zolotukhin, AS
    Felber, BK
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (17) : 11356 - 11360
123